Note: Ingredients listed on restricted chemical lists
EC/CAS
238-878-4/14808-60-7
Name of the chemical
Silica, crystalline
Concentration
≥50-≤75
EC/CAS
231-545-4/7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
≥10-≤25
EC/CAS
215-138-9/1305-78-8
Name of the chemical
Calcium oxide
Concentration
<3
General Information
Version
6.01
Revision date
2023-03-07
Product name
Resugrip Aggregate
1.2.1 Relevant identified uses
Paint or paint related material
1.2.2. Uses advised against
Industrial use only
Icons in SDS
Company Information
company name
Sherwin-Williams UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
hse.pm.emea@sherwin.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
2.2 Label elements
GPSTC
Signal word
Warning
Hazard statements
Causes serious eye irritation.
Prevention
Wear eye or face protection.
Response
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice or attention.
Storage
Not applicable.
Disposal
Not applicable.
Hazardous Ingredients
Calcium Oxide
Supplemental label elements
FOR INDUSTRIAL USE ONLY
Special packaging requirements
Not applicable.
2.3 Other hazards
This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Eye Irrit. 2, H319 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.